Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ductal Carcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03117855
What this trial is testing

Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery

Who this might be right for
Bile Duct AdenocarcinomaStage III Intrahepatic CholangiocarcinomaStage IVA Intrahepatic Cholangiocarcinoma+1 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Early research (Phase 1)Study completedNCT01709435
What this trial is testing

Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Recurrent Malignant Solid NeoplasmRecurrent MelanomaRecurrent Primary Central Nervous System Neoplasm+4 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Looking for participantsNCT07020221
What this trial is testing

VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon Small Cell Lung CancerColorectal Cancer+2 more
Verastem, Inc. 295
Testing effectiveness (Phase 2)WithdrawnNCT06592664
What this trial is testing

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Who this might be right for
Pancreas CancerPancreatic CarcinomaPancreas Adenocarcinoma+5 more
Lisata Therapeutics, Inc.
Not applicableWithdrawnNCT01791998
What this trial is testing

Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituInvasive Ductal Breast CarcinomaStage IA Breast Cancer+1 more
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT01661179
What this trial is testing

Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma

Who this might be right for
Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma
Genzyme, a Sanofi Company 14
Testing effectiveness (Phase 2)Looking for participantsNCT07117851
What this trial is testing

Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease

Who this might be right for
Extramammary Paget DiseaseScrotum Disease
Fudan University 20
Not applicableStudy completedNCT03664778
What this trial is testing

Abbreviated Breast MRI After Cancer Treatment

Who this might be right for
Breast NeoplasmsCarcinoma, Intraductal, Noninfiltrating
University of Pennsylvania 184
Not applicableUnknownNCT05703815
What this trial is testing

EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast

Who this might be right for
Invasive Breast Cancer
Sohag University 40
Testing effectiveness (Phase 2)UnknownNCT05278364
What this trial is testing

Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerSolid Tumor
Shouyao Holdings (Beijing) Co. LTD 184
Not applicableActive Not RecruitingNCT03583528
What this trial is testing

DOTATOC PET/CT for Imaging NET Patients

Who this might be right for
Neuroendocrine TumorsInsulinomaGastrinoma+13 more
British Columbia Cancer Agency 800
Testing effectiveness (Phase 2)Ended earlyNCT00582712
What this trial is testing

An Initial Study of Lithium in Patients With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
University of Wisconsin, Madison 5
Not applicableStudy completedNCT02856347
What this trial is testing

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

Who this might be right for
Medullary Thyroid Cancer
Institut Claudius Regaud 24
Not applicableStudy completedNCT05723978
What this trial is testing

Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.

Who this might be right for
Carcinoma, Pancreatic Ductal
Tianjin Medical University Cancer Institute and Hospital 520
Not applicableUnknownNCT05868252
What this trial is testing

Molecular Analysis of the Sloane Project

Who this might be right for
DCISLCISAtypical Ductal Hyperplasia+1 more
King's College London 1,500
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Testing effectiveness (Phase 2)Study completedNCT04704154
What this trial is testing

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

Who this might be right for
Solid Tumors
Bayer 175
Testing effectiveness (Phase 2)Looking for participantsNCT06561555
What this trial is testing

A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.

Who this might be right for
Mammary or Extramammary Paget's Disease
Fudan University 36
Next Page